ArticleOncoTargets and therapy2019

Decitabine enhances cytotoxic effect of T cells with an anti-CD19 chimeric antigen receptor in treatment of lymphoma.

Sujun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.